Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies
OmniActive is not only leading the nutraceutical industry in India but also shaping its global footprint. With an ever-increasing focus on R&D, product innovation, and strategic expansion, the company is poised to make significant contributions to the future of health and wellness. The integration of cutting-edge science with market-driven insights continues to position OmniActive as a key player in the nutraceutical space. With a clear roadmap for growth and a strong commitment to sustainability and quality, the company is setting new benchmarks in the industry. As it continues to evolve, its investments in R&D and innovation will be pivotal in driving the company forward. In this exclusive interview, Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies highlights how the company plans to not only meet but exceed market expectations. Edited Excerpts:
OmniActive has been investing heavily in its research and development (R&D) facilities. What has been the guiding vision behind this investment, and how do you foresee the future of R&D in the nutraceutical space evolving?
Our focus is B2B customers, and they are spread worldwide. In the global market, it is essential to introduce formulations that are new innovative and disruptive, which help our customers sell more of their offerings. This is why we invest heavily in R&D. Science and R&D are the two core pillars of our company. Without a strong foundation in science and technology, it is impossible to deliver anything useful in the nutraceutical industry. Our commitment to R&D enables us to stay ahead, ensuring that the products we bring to market not only meet current demands but also set the benchmark for future innovations.
To read more click on the link:https://nuffoodsspectrum.in/e-magazine